Changchun Kinsey Pharmaceuticals gets approval for long-acting human growth hormone

The hormone is modified by PEG and allows for reduced injections in children devoid of sufficient endogenous growth hormone. Changchun Kinsey Pharmaceuticals is a subsidiary of Changchun Hi-Tech Co.

China Bio news release, January 15, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny